Intestinal Polyposis Syndromes Clinical Presentation

  • Author: Evelyn K Hsu, MD; Chief Editor: Carmen Cuffari, MD   more...
 
Updated: Jan 3, 2011
 

History

Familial adenomatous polyposis

Familial adenomatous polyposis (FAP) presents with multiple adenomatous polyps throughout the colon (see the image below).

Familial adenomatous polyposis, total colectomy spFamilial adenomatous polyposis, total colectomy specimen. The colonic mucosa is studded with innumerable sessile and small pedunculated polyps, which involve the entire length of the specimen.

Eighty percent of these polyps present in the left colon. Patients with FAP are at risk for upper GI tract malignancies as well as for hepatoblastoma, which has an increased incidence in children with a family history of FAP.

In variants of FAP, manifestations can affect the entire body. Talbot classifies the manifestations of Gardner syndrome via tissue distribution.[38]

In most individuals, symptoms of polyposis manifest as sessile tubular adenomas in late adolescence; however, some individuals have developed polyps in early childhood.

Fundic gland polyps rarely develop into gastric cancer.

Mesodermal sites associated with Gardner syndrome include fibrous tissue (desmoid tumors), bone (osteomas, dental anomalies), and liver (hepatoblastoma).

Ectodermal tissues include the eyes (congenital hypertrophy of the retinal pigment [CHRPE]), skin (cysts), CNS (medulloblastoma), and endocrine system (thyroid carcinoma, multiple endocrine neoplasia 2B).

Van Meir classified the presentation of patients with Turcot syndrome into 2 categories, stratified by the presence or absence of colorectal phenotype.[29] Patients with medulloblastoma who expressed the colorectal phenotype were older than 17 years at disease onset, whereas patients with medulloblastoma in the absence of the colorectal phenotype were younger than 10 years at disease onset. Hamilton et al reported that several patients with Turcot syndrome have mutations in the APC gene.[15] These patients also have manifested ocular fundus lesions, epidermal inclusion cysts, and osteosclerotic jaw lesions consistent with Gardner syndrome.

Peutz-Jeghers Syndrome

Patients with Peutz-Jeghers syndrome (PJS) generally have with multiple pedunculated GI hamartomatous polyps, with lesions distributed through the small intestine (78%), colon (42%), stomach (38%), and rectum (28%).[39] They tend to present with the following symptoms:

  • GI bleeding
  • Intussusception
  • Rectal prolapse
  • Nasal polyposis (chronic sinusitis)
  • Pigmented macules on the lips and digits
  • Gynecomastia

The development of gynecomastia in a child with suspected PJS should prompt investigation for underlying testicular or gynecologic malignancy.

PTEN-hamartomatous syndromes

Features commonly associated with the entity that was known as Bannayan-Riley-Ruvalcaba (BRR) syndrome include increased weight and length at birth. Growth velocity generally tapers by the time the patient is aged 7 years.

Children often present with developmental delay, mild mental retardation, excessive drooling and hypotonia.

Cutaneous features frequently include lipomas (70% of patients), myopathy (60% of patients), hamartomatous GI polyps (45% of patients), hemangiomata (10% of patients), and telangiectasias. Typical dermatologic findings include vascular malformations, lipomatosis, speckled lentiginosis of the penis or vulva, facial verrucae–like or acanthosis nigricans–like lesions, and multiple acrochordons of the neck, axilla, and groin.

Other reported features include testicular enlargement, cryptorchidism, Hashimoto thyroiditis, and congenital heart disease (ventricular septal defect).

Gut malrotation has been documented in a patient.

Cowden disease, which is thought to be the same entity as BRR syndrome, manifests with variable penetrance at a later age and is typically associated with the following features:

  • Developmental delay
  • Macrocephaly (38%)
  • Cerebellar dysfunction
  • Scoliosis
  • Cutaneous hamartomas
  • Thyroid disease (>50%)
  • Chronic diarrhea
  • Malignancies: Neoplasia of the breast develops in 75% of females with Cowden disease. Other malignancies that have been reported in patients with Cowden disease include dysplastic gangliocytomas of the cerebellum, ovarian tumors, thyroid tumors, renal cell adenocarcinoma, and Merkel cell carcinomas
  • Visceral arteriovenous malformations: These malformations have been reported in a family diagnosed with Cowden syndrome and, based on genetic testing findings, were found to have a frameshift mutation in the PTEN gene.[40] This association has been attributed to hypothesized function of the PTEN gene in the suppression of angiogenesis.

Gorlin syndrome

Patients with Gorlin syndrome (GS) may present in infancy with congenital hydrocephalus, cleft lip and palate, lung cysts, rib and vertebral anomalies, and palmar pits. A case report by Genevieve et al described a child with GS who presented prenatally with a chylothorax.[41] Enamel hypoplasia has also been described in the dental literature and attributed to lyonization.

Children at risk for inheritance of the gene should undergo a detailed examination at birth to look for palmar pits and other physical features, as well as radiologic evaluation of the rib, skull, and spine.

Children with GS may present with symptoms of medulloblastoma when younger than 5 years.

Dental anomalies and basal cell carcinoma can appear in adolescents.

Familial juvenile polyposis

Usually, polyps vary in number, with variation in size and location. They can present with rectal bleeding, abdominal pain, and diarrhea.

Patients with familial juvenile polyposis (FJP) are diagnosed when the following criteria are met:

  • 5 (some sources say 10) juvenile polyps in the colon
  • Juvenile polyps throughout the GI tract
  • Any number of juvenile polyps with a family history of juvenile polyposis[42]

Associated congenital extracolonic anomalies are described in as many as 20% of these patients, ranging from neurologic (macrocephaly), thoracic (congenital heart disease), and urogenital, to GI(malrotation).[13] Congenital findings are more common in sporadic cases than the familial form of FJP.

Cronkhite-Canada syndrome

Cronkhite-Canada syndrome is a clinical syndrome with high mortality that presents with the following:

  • Generalized GI polyposis (sparing the esophagus)
  • Dermal pigmentation and atrophy of the nail beds
  • Severe protein-losing enteropathy with electrolyte disturbances[13]
Next

Physical

Familial adenomatous polyposis

  • Ocular: Congenital hypertrophy of the retinal pigment epithelium (characteristic pigmented fundus lesions) occur in roughly 70-80% of patients with FAP.[4]
  • GI: Multiple gastric polyps, multiple duodenal polyps, multiple colonic polyps, and mesenteric fibromas (desmoids) are noted.
  • Oncologic: Malignant transformation of polyps, gastric carcinoma, periampullary carcinoma, hepatoblastoma, biliary ductal carcinoma, osteosarcoma, adrenal carcinoma (Cushing syndrome), and thyroid carcinoma are noted.

Gardner syndrome

Physical features commonly associated with Gardner syndrome, addition to those listed above for FAP, include the following:

  • Skin - Epidermal cysts (commonly on the back), sebaceous cysts (commonly on the back)
  • Craniofacial - Osteomas (including the mandible), skin fibromas, dental anomalies (supernumerary teeth, impacted teeth, missing teeth, root anomalies)
  • Endocrine - Cushing syndrome (adrenal carcinoma), multiple endocrine neoplasia 2B

Turcot syndrome

Attributes of Turcot syndrome include the following:

  • Skin - Café au lait spots, multiple lipomas, basal cell carcinoma of the scalp
  • GI - Colonic polyps (including adenomatous), hepatic focal nodular hyperplasia, adenocarcinoma of the colon, gastric carcinoma
  • CNS - Glioma, glioblastoma multiforme, astrocytoma

Peutz-Jeghers Syndrome

The following findings are common in PJS:

  • Skin - Melanin spots on the lips, digits, and oral mucosa
  • GI - Multiple GI polyps (especially jejunal), intussusception, GI bleeding, rectal prolapse
  • Genitourinary (GU) - Polyps within ureter, bladder, and renal pelvis
  • Pulmonary - Nasal and bronchial polyps
  • Thorax - Gynecomastia (testis, ovarian tumors)

PTEN hamartomatous syndromes

Common findings associated with BRR include the following:

  • General - Increased weight and length at birth, macrocephaly, scaphocephaly, broad thumb and hallux
  • CNS - Hypotonia and myopathy, developmental delay, mild mental retardation
  • Cardiovascular - Arteriovenous malformation, congenital heart disease (eg, ventricular septal defect)
  • Pulmonary - Pectus excavatum
  • GI - High palate, hamartomatous intestinal polyps (colon, tongue)
  • GU - Enlarged penis, spotted pigment of glans penis, testicular enlargement
  • Ocular - Pseudopapilledema, exotropia

Manifestations of Cowden disease include the following:

  • Skin - Multiple hamartomas of skin and mucus membranes, verrucous lesions, papules of gingival and buccal mucosa, facial trichilemmomas (benign tumors of the lower outer root sheath epithelium of a hair follicle)
  • Cerebrospinal, head - Craniomegaly, adenoid facies, ataxia, increased intracranial pressure, cerebellar degeneration, mental retardation, tremors, tonsillar herniation, seizures
  • Endocrine - Thyroid hamartomas and carcinoma
  • Chest - Breast hamartomas and carcinomas, pectus excavatum
  • GI - Scrotal tongue, intestinal polyps (hamartomatous)
  • Oncology - Dysplastic cerebellar gangliocytoma, breast carcinoma, ovarian carcinomas, Merkel cell skin carcinomas, renal cell adenocarcinomas, thyroid carcinomas
  • Spine – Scoliosis

Gorlin syndrome

Physical characteristics associated with GS include the following:

  • Skin - Basal cell nevi and carcinoma
  • Craniofacial - Broad facies, including nasal root, bossing of frontal and parietal bones, cleft lip and palate, mandibular prognathism, dental anomalies (odontogenic keratocysts)
  • Ocular - Strabismus, hypertelorism, colobomas, subconjunctival epithelial cysts, glaucoma
  • Cardiac - Cardiac fibromas
  • Pulmonary - Congenital lung cyst, rib anomalies
  • GI - Hamartomatous gastric polyps, lymphomesenteric cysts
  • GU - Ovarian fibromas and carcinomas
  • CNS - Congenital hydrocephalus, mental retardation, medulloblastoma
  • Skeletal - Scoliosis, kyphoscoliosis, cervical anomalies, rib anomalies, brachydactyly, short fourth metacarpal and thumb

Familial juvenile polyposis

Common findings with FJP include the following:

  • GI - Numerous hamartomatous polyps throughout the GI tract that may cause bleeding or obstruction, malrotation, Meckel diverticulum
  • Cardiac - Congenital heart disease (eg, tetralogy of Fallot, atrial septal defect, coarctation of the aorta, patent ductus arteriosus, subvalvular aortic stenosis)
  • CNS - Macrocephaly, hydrocephalus, spina bifida
  • GI - Undescended testes, bifid uterus and vagina, abnormal UPJ insertion, unilateral renal agenesis
  • Skeletal - Osteoma

Cronkhite-Canada syndrome

This syndrome typically presents with complications from generalized polyposis associated with typical hyperpigmented skin findings.

Previous
Next

Causes

Familial adenomatous polyposis

FAP arises from mutations within the APC gene. The APC protein contains several functional regions that serve as binding and turnover loci for beta-catenin. Beta-catenin structures tissue architecture and activates E-cadherin, which regulates adherens junctions between epithelial cells. Based on experimental data within a Drosophila model, Peifer hypothesized that the APC complex governs the signaling of contact inhibition within the cell.[43]

Most mutations within the APC gene occur within the central area (mutation cluster region) and generate truncated APC proteins. Mutations situated within either the first or last third of the APC gene result in a late-onset attenuated polyposis phenotype; however, central region APC mutations exhibit a severe phenotype, with vast numbers of polyps occurring early in life and extracolonic manifestations.

Peutz-Jeghers syndrome

The cause for PJS appears to be multifactorial, although 80% of cases are associated with a gene mutation. Abnormalities in the STK11/LKB-1 gene, a serine-threonine kinase and tumor suppressor gene involved in the development of hamartomas, may facilitate the development of carcinomas. Additional mutation events may also be necessary for the development of PJS.

PTEN-hamartomatous syndromes

BRR syndrome and Cowden disease have been localized to band 10q23.3, which is the location of the PTEN, a tumor suppressor gene.[28, 44]

The phosphatase encoded by the PTEN gene functions within the phosphatidylinositol-3-kinase pathway, modulating the phosphoinositide-3-kinase signaling pathway via phosphorylation of phosphoinositides to regulate cell growth and survival.

Loss of gene function predisposes to future development of neoplasia.

Gorlin syndrome

GS has been mapped to band 9q22.3-q31. Studies by Hahn et al, Johnson et al, and Bale have explored similarities in GS to the Drosophila PTCH gene that is expressed in the sclerotome, branchial arch, limb, skin, and spinal cord.[45, 46, 47]

Bale noted that phenotypic expression of GS varied more among families, suggesting the importance of neighboring genes in modulation of phenotypic expression.[47]

Familial juvenile polyposis

FJP has been associated with gene mutations in SMAD4 and BMPR1A, which are proteins that function as mediators in the transforming growth factor b (TGF-b) pathway. This pathway has a role in regulating cell proliferation, differentiation, survival and apoptosis. An estimated 25% of cases are caused by an inherited defect in the gene; the other 75% arise from de novo mutations or environmental factor causes.

Previous
Proceed to Differential Diagnoses
 
 
Contributor Information and Disclosures
Author

Evelyn K Hsu, MD  Fellow in Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia

Disclosure: Nothing to disclose.

Coauthor(s)

Petar Mamula, MD  Associate Professor, Department of Pediatrics, Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine

Petar Mamula, MD, is a member of the following medical societies: American Academy of Pediatrics, American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and North American Society for Pediatric Gastroenterology and Nutrition

Disclosure: Nothing to disclose.

Eduardo D Ruchelli, MD  Associate Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine; Attending Physician, Department of Pathology, Children's Hospital of Philadelphia

Eduardo D Ruchelli, MD is a member of the following medical societies: Society for Pediatric Pathology and United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.

Specialty Editor Board

Jayant Deodhar, MD  Associate Professor in Pediatrics, BJ Medical College, India; Honorary Consultant, Departments of Pediatrics and Neonatology, King Edward Memorial Hospital, India

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Stefano Guandalini, MD  Director, Celiac Disease Center, Chief, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Chicago Medical Center; Professor, Department of Pediatrics, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine

Stefano Guandalini, MD is a member of the following medical societies: American Gastroenterological Association, European Society for Paediatric Gastroenterology, Hepatology & Nutrition, and North American Society for Pediatric Gastroenterology and Nutrition

Disclosure: Nothing to disclose.

Steven M Schwarz, MD, FAAP, FACN, AGAF  Professor of Pediatrics, Children's Hospital at Downstate, State University of New York Downstate Medical Center

Steven M Schwarz, MD, FAAP, FACN, AGAF is a member of the following medical societies: American Academy of Pediatrics, American College of Nutrition, American College of Physician Executives, American Gastroenterological Association, American Pediatric Society, Gastroenterology Research Group, New York Academy of Medicine, North American Society for Pediatric Gastroenterology and Nutrition, and Society for Pediatric Research

Disclosure: Curemark, LLC Consulting fee Board membership; Centocor, Inc. Grant/research funds Independent contractor; Johnson & Johnson, Inc. Grant/research funds Independent contractor

Chief Editor

Carmen Cuffari, MD  Associate Professor, Department of Pediatrics, Division of Gastroenterology/Nutrition, Johns Hopkins University School of Medicine

Carmen Cuffari, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

References

  1. Chargelaigue A. Des Polypes du Rectum. Thesis Paris. 1859.

  2. Turcot J, Despres JP, St Pierre F. Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases. Dis Colon Rectum. Sep-Oct 1959;2:465-8. [Medline].

  3. Baughman FA, List CF, Williams JR, et al. The glioma-polyposis syndrome. New England Journal of Medicine. 1969;281:1345-46. [Medline].

  4. Erdman SH. Pediatric adenomatous polyposis syndromes: an update. Curr Gastroenterol Rep. Jun 2007;9(3):237-44. [Medline].

  5. Peutz J. Very remarkable case of familial polyposis of mucous membrane of intestinal tract and nasopharynx accompanied by peculiar pigmentations of skin and mucous membrane. Nederl Maandschr Geneesk. 1921;10:1921.

  6. Jeghers H, McKusick VA, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med. Dec 22 1949;241(25):993, illust; passim. [Medline].

  7. Lloyd KM 2nd, Dennis M. Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med. Jan 1963;58:136-42. [Medline].

  8. Weary PE, Gorlin RJ, Gentry WC Jr, Comer JE, Greer KE. Multiple hamartoma syndrome (Cowden's disease). Arch Dermatol. Nov 1972;106(5):682-90. [Medline].

  9. Padberg GW, Schot JD, Vielvoye GJ, Bots GT, de Beer FC. Lhermitte-Duclos disease and Cowden disease: a single phakomatosis. Ann Neurol. May 1991;29(5):517-23. [Medline].

  10. HD Riley WS. Macrocephaly, pseudopapilledema and multiple hemangiomata: a previously undescribed heredofamilial syndrome. Pediatrics. 1960;26:293-300.

  11. Bannayan GA. Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. Arch Pathol. Jul 1971;92(1):1-5. [Medline].

  12. Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet. Sep 2007;44(9):579-85. [Medline].

  13. Calva D, Howe JR. Hamartomatous polyposis syndromes. Surg Clin North Am. Aug 2008;88(4):779-817, vii. [Medline].

  14. Gorlin RJ. Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore). Mar 1987;66(2):98-113. [Medline].

  15. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM. The molecular basis of Turcot's syndrome. N Engl J Med. Mar 30 1995;332(13):839-47. [Medline].

  16. Tops CM, Vasen HF, van Berge Henegouwen G, et al. Genetic evidence that Turcot syndrome is not allelic to familial adenomatous polyposis. Am J Med Genet. Jul 15 1992;43(5):888-93. [Medline].

  17. Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. Jan 8 1998;391(6663):184-7. [Medline].

  18. Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. Jan 1998;18(1):38-43. [Medline].

  19. Volikos E, Robinson J, Aittomäki K, Mecklin JP, Järvinen H, Westerman AM. LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet. May 2006;43(5):e18. [Medline].

  20. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. Feb 16 1999;96(4):1563-8. [Medline].

  21. Jones KL, Smith DW, Harvey MA, Hall BD, Quan L. Older paternal age and fresh gene mutation: data on additional disorders. J Pediatr. Jan 1975;86(1):84-8. [Medline].

  22. Bisgaard ML, Fenger K, Bülow S, Niebuhr E, Mohr J. Familial adenomatous polyposis (FAP): frequency, penetrance, and mutation rate. Hum Mutat. 1994;3(2):121-5. [Medline].

  23. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: two genetic diseases?. J Clin Oncol. Jul 1997;15(7):2744-58. [Medline].

  24. Krush AJ, Giardiello FM. Development of a genetics registry: Hereditary intestinal polyposis and hereditary colon cancer registry at the Johns Hopkins Hospital, 1973-1988. In: Herrera L. Familial Adenomatous Polyposis. New York, NY: Alan R. Liss Inc; 1990.

  25. Farndon PA, Del Mastro RG, Evans DG, Kilpatrick MW. Location of gene for Gorlin syndrome. Lancet. Mar 7 1992;339(8793):581-2. [Medline].

  26. Burn J, Chapman P, Delhanty J, Wood C, Lalloo F, Cachon-Gonzalez MB. The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet. May 1991;28(5):289-96. [Medline].

  27. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. Oct 15 2007;21(20):2525-38. [Medline].

  28. Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet. Apr 1999;7(3):267-73. [Medline].

  29. Van Meir EG. "Turcot's syndrome": phenotype of brain tumors, survival and mode of inheritance. Int J Cancer. Jan 5 1998;75(1):162-4. [Medline].

  30. Giardiello FM, Brensinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. Jul 2001;121(1):198-213. [Medline].

  31. Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. Mar 31 1997;69(3):299-308. [Medline].

  32. Klemmer S, Pascoe L, DeCosse J. Occurrence of desmoids in patients with familial adenomatous polyposis of the colon. Am J Med Genet. Oct 1987;28(2):385-92. [Medline].

  33. Bell B, Mazzaferri EL. Familial adenomatous polyposis (Gardner's syndrome) and thyroid carcinoma. A case report and review of the literature. Dig Dis Sci. Jan 1993;38(1):185-90. [Medline].

  34. Hanssen AM, Fryns JP. Cowden syndrome. J Med Genet. Feb 1995;32(2):117-9. [Medline].

  35. Distante S, Nasioulas S, Somers GR, Cameron DJ, Young MA, Forrest SM. Familial adenomatous polyposis in a 5 year old child: a clinical, pathological, and molecular genetic study. J Med Genet. Feb 1996;33(2):157-60. [Medline].

  36. Fernandez Seara MJ, Martinez Soto MI, Fernandez Lorenzo JR, Trabazo S, Gamborino E, Forteza Vila J. Peutz-Jeghers syndrome in a neonate. J Pediatr. Jun 1995;126(6):965-7. [Medline].

  37. Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. Nov 2008;16(11):1289-300. [Medline].

  38. Talbot I. Pathology. In: Phillips RKS SA, Thompson JPS. Familial Adenomatous Polyposis and Other Polyposis Syndrome. Oxford UP; 1994:15-35.

  39. Hemminki A. The molecular basis and clinical aspects of Peutz-Jeghers syndrome. Cell Mol Life Sci. May 1999;55(5):735-50. [Medline].

  40. Tan WH, Baris HN, Burrows PE, Robson CD, Alomari AI, Mulliken JB. The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet. Sep 2007;44(9):594-602. [Medline].

  41. Genevieve D, Walter E, Gorry P, Jacquemont ML, Dupic L, Layet V. Gorlin syndrome presenting as prenatal chylothorax in a girl. Prenat Diagn. Nov 2005;25(11):997-9. [Medline].

  42. Sachatello CR, Hahn IS, Carrington CB. Juvenile gastrointestinal polyposis in a female infant: report of a case and review of the literature of a recently recognized syndrome. Surgery. Jan 1974;75(1):107-14. [Medline].

  43. Peifer M. Cancer, catenins, and cuticle pattern: a complex connection. Science. Dec 10 1993;262(5140):1667-8. [Medline].

  44. Arch EM, Goodman BK, Van Wesep RA, Liaw D, Clarke K, Parsons R. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet. Sep 5 1997;71(4):489-93. [Medline].

  45. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell. Jun 14 1996;85(6):841-51. [Medline].

  46. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science. Jun 14 1996;272(5268):1668-71. [Medline].

  47. Bale AE. Variable expressivity of patched mutations in flies and humans. Am J Hum Genet. Jan 1997;60(1):10-2. [Medline].

  48. Winawer SJ, Zauber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. May 2006;130(6):1872-85. [Medline].

  49. Sidhu R, Sanders DS, McAlindon ME, Thomson M. Capsule endoscopy and enteroscopy: modern modalities to investigate the small bowel in paediatrics. Arch Dis Child. Feb 2008;93(2):154-9. [Medline].

  50. de' Angelis GL, Fornaroli F, de' Angelis N, Magiteri B, Bizzarri B. Wireless capsule endoscopy for pediatric small-bowel diseases. Am J Gastroenterol. Aug 2007;102(8):1749-57; quiz 1748, 1758. [Medline].

  51. Gruber SB, Entius MM, Petersen GM, et al. Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res. Dec 1 1998;58(23):5267-70. [Medline].

  52. Bulow S. Results of national registration of familial adenomatous polyposis. Gut. May 2003;52(5):742-6. [Medline].

  53. Howe JR, Mitros FA, Summers RW. The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol. Dec 1998;5(8):751-6. [Medline].

  54. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J. Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology. Feb 2003;124(2):544-60. [Medline].

  55. Attard TM, Cuffari C, Tajouri T, Stoner JA, Eisenberg MT, Yardley JH. Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis. Am J Gastroenterol. Apr 2004;99(4):681-6. [Medline].

  56. Barnard J. Screening and surveillance recommendations for pediatric gastrointestinal polyposis syndromes. J Pediatr Gastroenterol Nutr. Apr 2009;48 Suppl 2:S75-8. [Medline].

  57. Hughes LJ, Michels VV. Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet. Aug 1 1992;43(6):1023-5. [Medline].

  58. Burt RW. Colon cancer screening. Gastroenterology. Sep 2000;119(3):837-53. [Medline].

  59. Church JM, McGannon E, Burke C, Clark B. Teenagers with familial adenomatous polyposis: what is their risk for colorectal cancer?. Dis Colon Rectum. Jul 2002;45(7):887-9. [Medline].

  60. Howe JR, Roth S, Ringold JC, et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. May 15 1998;280(5366):1086-8. [Medline].

  61. Howe JR, Ringold JC, Hughes JH, Summers RW. Direct genetic testing for Smad4 mutations in patients at risk for juvenile polyposis. Surgery. Aug 1999;126(2):162-70. [Medline].

  62. Jänne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. Jun 29 2000;342(26):1960-8. [Medline].

  63. Yang K, Yang W, Mariadason J, Velcich A, Lipkin M, Augenlicht L. Dietary components modify gene expression: implications for carcinogenesis. J Nutr. Nov 2005;135(11):2710-4. [Medline].

  64. Macrae F. Wheat bran fiber and development of adenomatous polyps: evidence from randomized, controlled clinical trials. Am J Med. Jan 25 1999;106(1A):38S-42S. [Medline].

  65. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Stampfer MJ, Rosner B. Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med. Jan 21 1999;340(3):169-76. [Medline].

  66. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. May 6 1993;328(18):1313-6. [Medline].

  67. Ruhswurm I, Zehetmayer M, Dejaco C, Wolf B, Karner-Hanusch J. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis. Am J Ophthalmol. May 1998;125(5):680-6. [Medline].

  68. Watanabe K, Kawamori T, Nakatsugi S, Ohta T, Ohuchida S, Yamamoto H. Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis. Cancer Res. Oct 15 1999;59(20):5093-6. [Medline].

 
Previous
Next
 
Familial adenomatous polyposis, total colectomy specimen. The colonic mucosa is studded with innumerable sessile and small pedunculated polyps, which involve the entire length of the specimen.
Pedunculated tubular adenoma. Note the contrast between the goblet cell-rich glands along the pedicle of the polyp and in the underlying normal colonic mucosa at the bottom and the dysplastic glands in the polyp proper. The dysplastic glands are more crowded and exhibit decreased mucin production. (Hematoxylin and eosin stain; 1X magnification).
Sessile tubular adenoma. The glands on the superficial aspect of the specimen are dysplastic and exhibit increased nuclear size, hyperchromasia, crowding, and decreased mucin production. (Hematoxylin and eosin stain, 4X magnification).
Hamartomatous (Peutz-Jeghers) polyp, small bowel. This pedunculated polyp has a cerebriform appearance due to the arborizing frond-like growth with delicate finger-like projections of the stroma. (Hematoxylin and eosin stain, 1X magnification).
Hamartomatous (Peutz-Jeghers) polyp, small bowel. Closer view of the fingerlike projections of the stroma demonstrates prominent smooth muscle fascicles between the glandular elements. (Hematoxylin and eosin stain, 4X magnification).
Hamartomatous polyp, as seen in the stomach. (Endoscopic image).
Colon in familial adenomatous polyposis (FAP). (Endoscopic image).
Small bowel polyp. (Video capsule image).
Multiple large polyps in the colon. The polyp in the center of the image is situated on a stalk. (Endoscopic image).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.